Aclaris Therapeutics News Headlines (NASDAQ:ACRS)

$1.42
+0.03 (+2.16 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
$1.37
Now: $1.42
$1.54
50-Day Range
$0.77
MA: $1.04
$2.00
52-Week Range
$0.74
Now: $1.42
$15.98
Volume1.63 million shs
Average Volume2.62 million shs
Market Capitalization$58.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81

Headlines

Aclaris Therapeutics (NASDAQ ACRS) News Headlines

Source:
DateHeadline
Aclaris Therapeutics (NASDAQ:ACRS) Rating Reiterated by William BlairAclaris Therapeutics (NASDAQ:ACRS) Rating Reiterated by William Blair
www.americanbankingnews.com - September 20 at 12:23 PM
Equities Analysts Offer Predictions for Aclaris Therapeutics Incs Q3 2019 Earnings (NASDAQ:ACRS)Equities Analysts Offer Predictions for Aclaris Therapeutics Inc's Q3 2019 Earnings (NASDAQ:ACRS)
www.americanbankingnews.com - September 19 at 6:43 AM
Mid-Day Market Update: Crude Oil Down 5.5%; Aclaris Therapeutics Shares Spike HigherMid-Day Market Update: Crude Oil Down 5.5%; Aclaris Therapeutics Shares Spike Higher
www.benzinga.com - September 18 at 8:58 PM
25 Stocks Moving in Tuesdays Pre-Market Session25 Stocks Moving in Tuesday's Pre-Market Session
www.msn.com - September 18 at 8:58 PM
Why Microcap Biotech Aclaris Is RallyingWhy Microcap Biotech Aclaris Is Rallying
www.benzinga.com - September 18 at 8:58 PM
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 18 at 8:58 PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aclaris Therapeutics, Carbonite, GTT Communications, and Just Energy and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aclaris Therapeutics, Carbonite, GTT Communications, and Just Energy and Encourages Investors to Contact the Firm
finance.yahoo.com - September 18 at 8:58 PM
Aclaris A-101 successful in late-stage wart studyAclaris' A-101 successful in late-stage wart study
seekingalpha.com - September 16 at 7:29 PM
Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
finance.yahoo.com - September 16 at 7:29 PM
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 16 at 7:29 PM
UPCOMING DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmUPCOMING DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 16 at 11:28 AM
ACRS NOTICE, ROSEN, A LEADING FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action - ACRSACRS NOTICE, ROSEN, A LEADING FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action - ACRS
finance.yahoo.com - September 16 at 11:28 AM
GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLCGTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - September 16 at 11:28 AM
SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmSHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 2:55 PM
GLOBALLY RECOGNIZED ROSEN LAW FIRM Reminds...GLOBALLY RECOGNIZED ROSEN LAW FIRM Reminds...
www.benzinga.com - September 14 at 6:18 AM
Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRSZhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRS
finance.yahoo.com - September 14 at 6:18 AM
Aclaris Therapeutics Inc (NASDAQ:ACRS) Expected to Post Quarterly Sales of $5.87 MillionAclaris Therapeutics Inc (NASDAQ:ACRS) Expected to Post Quarterly Sales of $5.87 Million
www.americanbankingnews.com - September 12 at 1:21 AM
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 11 at 10:56 PM
Heres why Aclaris is laying off half of its staffHere's why Aclaris is laying off half of its staff
www.bizjournals.com - September 11 at 5:50 PM
INVESTOR ALERT - Aclaris Therapeutics, Inc. (ACRS) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: September 30, 2019INVESTOR ALERT - Aclaris Therapeutics, Inc. (ACRS) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: September 30, 2019
finance.yahoo.com - September 11 at 5:50 PM
-$0.62 EPS Expected for Aclaris Therapeutics Inc (NASDAQ:ACRS) This Quarter-$0.62 EPS Expected for Aclaris Therapeutics Inc (NASDAQ:ACRS) This Quarter
www.americanbankingnews.com - September 10 at 10:12 PM
Chester County biopharmaceutical firm cutting 86 jobsChester County biopharmaceutical firm cutting 86 jobs
finance.yahoo.com - September 10 at 7:58 AM
UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmUPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 10 at 7:58 AM
Shareholder Alert: Robbins Arroyo LLP Reminds Shareholders That Aclaris Therapeutics, Inc. (ACRS) Sued for Misleading ShareholdersShareholder Alert: Robbins Arroyo LLP Reminds Shareholders That Aclaris Therapeutics, Inc. (ACRS) Sued for Misleading Shareholders
finance.yahoo.com - September 10 at 7:58 AM
Aclaris Therapeutics Inc (NASDAQ:ACRS) Given Consensus Recommendation of "Hold" by AnalystsAclaris Therapeutics Inc (NASDAQ:ACRS) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 8 at 6:33 AM
ACRS DEADLINE: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRSACRS DEADLINE: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRS
finance.yahoo.com - September 6 at 11:32 PM
Pomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRSPomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRS
finance.yahoo.com - September 6 at 1:32 PM
Pomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRSPomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRS
finance.yahoo.com - September 6 at 1:32 PM
Aclaris Therapeutics (NASDAQ:ACRS) Rating Lowered to Market Perform at JMP SecuritiesAclaris Therapeutics (NASDAQ:ACRS) Rating Lowered to Market Perform at JMP Securities
www.americanbankingnews.com - September 6 at 8:25 AM
HIGHLY RANKED ROSEN LAW FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRSHIGHLY RANKED ROSEN LAW FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRS
finance.yahoo.com - September 2 at 6:12 PM
ROSEN, A LEADING FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class ActionROSEN, A LEADING FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action
finance.yahoo.com - August 30 at 5:46 AM
IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 29 at 11:31 AM
ACRS: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRSACRS: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 27 at 9:21 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oasmia Pharmaceutical, Aclaris Therapeutics, Evolent Health, and International Flavors & Fragrances and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oasmia Pharmaceutical, Aclaris Therapeutics, Evolent Health, and International Flavors & Fragrances and Encourages Investors to Contact the Firm
finance.yahoo.com - August 27 at 9:21 AM
IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 7:01 PM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 23 at 9:39 AM
Aclaris (ACRS) Upgraded to Buy: Heres What You Should KnowAclaris (ACRS) Upgraded to Buy: Here's What You Should Know
www.nasdaq.com - August 21 at 8:44 PM
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmINVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 20 at 11:52 AM
ACRS LOSS NOTICE: ROSEN, A LEADING FIRM, Announces Filing of Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ACRSACRS LOSS NOTICE: ROSEN, A LEADING FIRM, Announces Filing of Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ACRS
finance.yahoo.com - August 19 at 7:25 PM
Aclaris Therapeutics halts marketing efforts for one of its skin disorder drugsAclaris Therapeutics halts marketing efforts for one of its skin disorder drugs
finance.yahoo.com - August 16 at 7:39 PM
Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRSZhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 16 at 7:39 PM
Edited Transcript of ACRS earnings conference call or presentation 8-Aug-19 9:00pm GMTEdited Transcript of ACRS earnings conference call or presentation 8-Aug-19 9:00pm GMT
finance.yahoo.com - August 14 at 8:16 AM
Aclaris Is Worth A Look After Positive Data And Strategic Review PotentialAclaris Is Worth A Look After Positive Data And Strategic Review Potential
seekingalpha.com - August 13 at 12:42 AM
ROSEN, A LEADING LAW FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRSROSEN, A LEADING LAW FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRS
finance.yahoo.com - August 13 at 12:42 AM
Aclaris Therapeutics, Inc. Institutional OwnershipAclaris Therapeutics, Inc. Institutional Ownership
www.nasdaq.com - August 9 at 8:07 PM
Aclaris Therapeutics, Inc. Common Stock Historical Stock PricesAclaris Therapeutics, Inc. Common Stock Historical Stock Prices
www.nasdaq.com - August 9 at 8:07 PM
ACLARIS THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Southern District of New York against Aclaris Therapeutics, Inc.ACLARIS THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Southern District of New York against Aclaris Therapeutics, Inc.
finance.yahoo.com - August 7 at 7:58 PM
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmINVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 6 at 7:56 PM
Zhang Investor Law Announces Securities Class Action Lawsuit Aclaris Therapeutics, Inc. – ACRSZhang Investor Law Announces Securities Class Action Lawsuit Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 6 at 7:56 PM
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc.Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc.
finance.yahoo.com - August 6 at 7:56 PM
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel